DE3448494C2 - - Google Patents

Info

Publication number
DE3448494C2
DE3448494C2 DE3448494A DE3448494A DE3448494C2 DE 3448494 C2 DE3448494 C2 DE 3448494C2 DE 3448494 A DE3448494 A DE 3448494A DE 3448494 A DE3448494 A DE 3448494A DE 3448494 C2 DE3448494 C2 DE 3448494C2
Authority
DE
Germany
Prior art keywords
milk
hyperimmune
smoke
rats
exposed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3448494A
Other languages
German (de)
English (en)
Inventor
Ralph J. Oregonia Ohio Us Stolle
Lee R. Dr. Birmingham Ala. Us Beck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stolle Milk Biologics Inc
Original Assignee
Stolle Research & Development Corp Cincinnatti Ohio Us
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Research & Development Corp Cincinnatti Ohio Us filed Critical Stolle Research & Development Corp Cincinnatti Ohio Us
Application granted granted Critical
Publication of DE3448494C2 publication Critical patent/DE3448494C2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39508—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from milk, i.e. lactoglobulins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE3448494A 1983-10-27 1984-10-26 Expired - Lifetime DE3448494C2 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/546,162 US4636384A (en) 1982-06-03 1983-10-27 Method for treating disorders of the vascular and pulmonary systems

Publications (1)

Publication Number Publication Date
DE3448494C2 true DE3448494C2 (enExample) 1993-09-23

Family

ID=24179138

Family Applications (2)

Application Number Title Priority Date Filing Date
DE3448494A Expired - Lifetime DE3448494C2 (enExample) 1983-10-27 1984-10-26
DE3439345A Expired - Lifetime DE3439345C2 (de) 1983-10-27 1984-10-26 Verwendung von hyperimmuner Milch zur Behandlung von Herzgefäßerkrankungen bei Tier und Mensch

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE3439345A Expired - Lifetime DE3439345C2 (de) 1983-10-27 1984-10-26 Verwendung von hyperimmuner Milch zur Behandlung von Herzgefäßerkrankungen bei Tier und Mensch

Country Status (7)

Country Link
US (1) US4636384A (enExample)
EP (2) EP0380032B1 (enExample)
AT (2) ATE64530T1 (enExample)
CH (1) CH671517A5 (enExample)
DE (2) DE3448494C2 (enExample)
NL (1) NL8403248A (enExample)
SE (1) SE466532B (enExample)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814345A (en) * 1982-06-03 1998-09-29 Stolle Research & Development Corporation Immune suppressive product
US4879110A (en) * 1983-10-27 1989-11-07 Stolle Research And Development Corporation Antihypertensive hyperimmune milk, production, composition, and use
US4956349A (en) * 1983-10-27 1990-09-11 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5932250A (en) * 1982-06-03 1999-08-03 Dcv, Inc. Anti-cholesterolemic egg, vaccine and method for production, and use
US5215746A (en) * 1982-06-03 1993-06-01 Stolle Research And Development Corporation Anti-cholesterolemic egg, vaccine and method for production, and use
US5352462A (en) * 1982-06-03 1994-10-04 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5753268A (en) * 1982-06-03 1998-05-19 Dcv Biologics, L.P. Anti-cholesterolemic egg, vaccine and method for production, and use
US5650175A (en) * 1982-06-03 1997-07-22 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5242691A (en) * 1982-06-03 1993-09-07 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US4897265A (en) * 1983-10-27 1990-01-30 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
US5849349A (en) * 1982-06-03 1998-12-15 Dcv, Inc. Anti-cholesterolemic egg, vaccine and method for production, and use
US5194255A (en) * 1982-06-03 1993-03-16 Stolle Research & Development Corporation Antihypertensive hyperimmune milk, production, composition, and use
US5130128A (en) * 1982-06-03 1992-07-14 Stolle Research & Development Corporation Use of honey as vaccine
US6054124A (en) * 1982-06-03 2000-04-25 Stolle Milk Biologics, Inc. Immune suppressive product
US4994496A (en) * 1987-09-09 1991-02-19 Repasky Elizabeth A Use of milk globules as carriers for drugs
AU629559B2 (en) * 1988-08-04 1992-10-08 Thomas Julius Borody Oral antibody therapy for patients with lowered immune response and composition therefor
US5128127A (en) * 1989-02-08 1992-07-07 Stolle Research & Development Corp. Increased protein production in animals
EP0646017A1 (en) * 1990-07-05 1995-04-05 The Stolle Research And Development Corporation Immune suppressive product
US20080139789A1 (en) * 1990-10-22 2008-06-12 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated Broadly Reactive Opsonic Immunoglobulin for Treating a Pathogenic Coagulase-Negative Staphylococcus Infection
NZ299579A (en) * 1992-06-16 2000-09-29 Stolle Milk Biologics Inc ue of hyperimmune milk to restore decreasing physiologic function
US6056978A (en) * 1992-06-16 2000-05-02 Stolle Milk Biologics, Inc. Use of hyperimmune milk to prevent suppression of T-lymphocyte production
NZ254326A (en) * 1993-05-26 1998-01-26 Dcv Inc Substituted Under Sect An anti-cholesterol egg, its production and use
US5980953A (en) * 1994-10-03 1999-11-09 Stolle Milk Biologics, Inc. Anti-inflammatory factor, method of isolation, and use
FI955389A0 (fi) * 1995-11-09 1995-11-09 Antti Sakari Aaltonen Tandskyddande profylaktisk preparat och administreringsmedlen emot mellanoerpatogener
US20020161199A1 (en) * 1998-04-08 2002-10-31 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US5980044A (en) * 1998-09-16 1999-11-09 Evans & Sutherland Computer Corp. Area of interest display system with image combining using error dithering
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
US20030108617A1 (en) * 2000-06-28 2003-06-12 Ulrich Leithe Use of a formulation made of or containing at least one dissimilated milk serum
US20030190314A1 (en) * 2001-01-30 2003-10-09 The Lauridsen Group Methods and compositions of treatment for modulating the immune system of animals
BR0206869A (pt) * 2001-01-30 2007-01-02 Lauridsen Group Inc método para o tratamento de um animal sofrendo de um estado doentio de disfunção imune associado com nìveis alterados de igg ou tnf-delta, composição farmacêutica para o tratamento de distúrbios auto-imunes associados com elevados igg e/ou tnf-delta ou para a potenciação de protocolos de vacina, e método para o tratamento de estado doentio associado com disfunção imune em um animal
PL214224B1 (pl) * 2001-01-30 2013-07-31 Lauridsen Group Doustna forma koncentratu nie - hiperimmunizowanych nie-specyficznych immunoglobulin oraz suplement diety
US6770280B1 (en) 2001-11-15 2004-08-03 Humanetics Corporation Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product
US20030223985A1 (en) * 2002-05-29 2003-12-04 The Lauridsen Group. Incorporated Globulin protein to lower cholesterol in humans
US20060013890A1 (en) * 2004-06-24 2006-01-19 Green Shawn J Dairy-derived anticholesterol immunoglobulin to lower dietary cholesterol in humans
US20070087002A1 (en) * 2005-10-14 2007-04-19 Green Shawn J Anticholesterol immunoglobulin to treat lipid raft diseases
US7891818B2 (en) 2006-12-12 2011-02-22 Evans & Sutherland Computer Corporation System and method for aligning RGB light in a single modulator projector
US8358317B2 (en) 2008-05-23 2013-01-22 Evans & Sutherland Computer Corporation System and method for displaying a planar image on a curved surface
US8702248B1 (en) 2008-06-11 2014-04-22 Evans & Sutherland Computer Corporation Projection method for reducing interpixel gaps on a viewing surface
US8077378B1 (en) 2008-11-12 2011-12-13 Evans & Sutherland Computer Corporation Calibration system and method for light modulation device
US9641826B1 (en) 2011-10-06 2017-05-02 Evans & Sutherland Computer Corporation System and method for displaying distant 3-D stereo on a dome surface

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128230A (en) * 1961-04-04 1964-04-07 Sunbury Milk Products Co Milk having antibodies therein and process for producing same
US3376198A (en) * 1965-07-21 1968-04-02 Collins Products Inc Method of producing antibodies in milk
US3911108A (en) * 1973-02-14 1975-10-07 Diamond Shamrock Corp Process of producing bovine milk products containing specific antibodies
US4324782A (en) * 1974-01-28 1982-04-13 Beck Lee R Dental caries inhibiting product of immunized cow's milk having antibodies specific to killed Streptococcus mutans cells
GB1505513A (en) * 1975-05-23 1978-03-30 Stolle Res & Dev Dental caries inhibiting product
SE448344B (sv) * 1978-02-06 1987-02-16 Stolle Res & Dev Antikropp for behandling av reumatoid artrit samt sett att framstella denna
US4284623A (en) * 1979-11-09 1981-08-18 Beck Lee R Method of treating inflammation using bovine milk
US4377569A (en) * 1980-01-21 1983-03-22 Plymate Robert R Method of treating animals to resist infectious diseases
DE3172807D1 (en) * 1981-04-28 1985-12-12 Stolle Res & Dev Method of obtaining an anti-inflammatory bovine milk

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS ERMITTELT *

Also Published As

Publication number Publication date
HK1006004A1 (en) 1999-02-05
EP0380032A1 (en) 1990-08-01
CH671517A5 (enExample) 1989-09-15
EP0143345A2 (en) 1985-06-05
DE3439345C2 (de) 1993-10-14
EP0380032B1 (en) 1994-01-19
ATE64530T1 (de) 1991-07-15
SE8405351D0 (sv) 1984-10-26
SE466532B (sv) 1992-03-02
NL8403248A (nl) 1985-05-17
SE8405351L (sv) 1985-04-28
EP0143345B1 (en) 1991-06-19
ATE100325T1 (de) 1994-02-15
DE3439345A1 (de) 1986-04-24
EP0143345A3 (en) 1987-09-30
US4636384A (en) 1987-01-13

Similar Documents

Publication Publication Date Title
DE3448494C2 (enExample)
DE2813984C2 (enExample)
DE3504221C2 (de) Mittel zur passiven Immunisierung von Säugern
EP1964570B1 (de) Pharmazeutische Zusammensetzung zum Schutz vor Allergien und entzündlichen Erkrankungen
DE3689717T2 (de) Einen spezifischen Antikörper enthaltender Stoff aus Eiern, Verfahren zu dessen Herstellung und seine Anwendung.
DE68923310T2 (de) Antientzündungsfaktor aus Milch.
DE3024623C2 (enExample)
DE2904044C2 (de) Immungammaglobulin-(IgG)-Präparat, Verfahren zu seiner Herstellung und dessen Verwendung
DE2458327A1 (de) Rinder-immunoglobulin-isolierungsverfahren
DE69130323T2 (de) Entzündungshemmender faktor, verfahren zur isolation und verwendung
DE68906054T2 (de) Hyperimmunizierte milch gegen bluthochdruck.
DE1810438A1 (de) Prophylaktisches oder therapeutisches Praeparat
DE69737191T2 (de) Entzündungshemmende Zusammensetzung aus Ei, Verfahren zur Isolierung und Verwendung
DE69032646T2 (de) Eine caseinfraktion zur therapeutischen vorbeugenden und/oder diagnostischen verwendung bei atemweginfektionen
EP1411977B1 (de) Zusammensetzung, enthaltend bakterielle antigene, zum vorbeugen und behandeln von allergischen erkrankungen
DE69434000T3 (de) Impfstoffzusammensetzungen
DE69331957T2 (de) Antiinflammatorischen faktor enthaltende zusammensetzungen , verfahren zur herstellung und verwendung
DE69028219T2 (de) Verwendung von honig als impfstoff
DE602004005963T2 (de) Verwendung von vogelantikörpern
DE2639012A1 (de) Immuntherapeutikum zur prophylaxe und therapie von pseudomonas aeruginosa- infektionen und verfahren zu seiner herstellung
DE69525060T2 (de) Entzündungshemmende faktor, methode seiner isolation und verwendung
DE3249251T1 (de) Therapeutische Mittel zur Behandlung von allergischen Störungen, Immunkomplexerkrankungen und Tumoren
DE1902590C2 (de) Verwendung einer Immunribonucleinsäure (IRNS) zum Immunisieren lebender Tiere
DE69331836T2 (de) Anti-cholesterin ei, impfstoff, herstellungsmethode und verwendung
DE2001671C3 (de) Plyvalentes Mastits-Immunglobulin und dessen Verwendung bei der Bekämpfung der Mastits

Legal Events

Date Code Title Description
Q172 Divided out of (supplement):

Ref country code: DE

Ref document number: 3439345

8110 Request for examination paragraph 44
AC Divided out of

Ref country code: DE

Ref document number: 3439345

Format of ref document f/p: P

D2 Grant after examination
AC Divided out of

Ref country code: DE

Ref document number: 3439345

Format of ref document f/p: P

8339 Ceased/non-payment of the annual fee
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: STOLLE MILK BIOLOGICS, INC., CINCINNATI, OHIO, US